Patient info Open main menu

L01XC Monoclonal antibodies, antineoplastic

ATC group of level 4 – chemical subgroup · in plain English: cancer medicines

This site has the patient leaflet or the SPC of 73 medicines in this group and its subgroups.

Place in the ATC classification

  1. L Antineoplastic and immunomodulating agents 1,791 medicines
    1. L01 Antineoplastic agents 1,025 medicines
      1. L01X Other antineoplastic agents 225 medicines
        1. L01XC Monoclonal antibodies, antineoplastic 73 medicines
          1. L01XC02 rituximab 10 medicines
          2. L01XC03 trastuzumab 14 medicines
          3. L01XC05 gemtuzumab ozogamicin 1 medicine
          4. L01XC06 cetuximab 1 medicine
          5. L01XC07 bevacizumab 12 medicines
          6. L01XC08 panitumumab 1 medicine
          7. L01XC09 catumaxomab 1 medicine
          8. L01XC10 ofatumumab 1 medicine
          9. L01XC11 ipilimumab 1 medicine
          10. L01XC12 brentuximab vedotin 1 medicine
          11. L01XC13 pertuzumab 1 medicine
          12. L01XC14 trastuzumab emtansine 2 medicines
          13. L01XC15 obinutuzumab 1 medicine
          14. L01XC16 dinutuximab beta 1 medicine
          15. L01XC17 nivolumab 2 medicines
          16. L01XC19 blinatumomab 2 medicines
          17. L01XC21 ramucirumab 1 medicine
          18. L01XC24 daratumumab 2 medicines
          19. L01XC25 mogamulizumab 1 medicine
          20. L01XC26 inotuzumab ozogamicin 1 medicine
          21. L01XC27 olaratumab 1 medicine
          22. L01XC28 durvalumab 1 medicine
          23. L01XC31 avelumab 1 medicine
          24. L01XC32 atezolizumab 1 medicine
          25. L01XC33 cemiplimab 1 medicine
          26. L01XC35 tafasitamab 1 medicine
          27. L01XC38 isatuximab 1 medicine
          28. L01XC39 belantamab mafodotin 2 medicines
          29. L01XC40 dostarlimab 1 medicine

9 more subgroups have no medicine with a leaflet on this site.

Active substances in the group

Medicines in the group and its subgroups

MedicineLegal category
Abevmy 25 mg / ml concentrate for solution for infusion SPC (L01XC07 bevacizumab) –
Adcetris 50 mg powder for concentrate for solution for infusion (L01XC12 brentuximab vedotin) Prescription only (POM)
Alymsys SPC (L01XC07 bevacizumab) Prescription only (POM)
Arzerra SPC no longer supplied (L01XC10 ofatumumab) –
Avastin 25 mg / ml concentrate for solution for infusion SPC (L01XC07 bevacizumab) –
Aybintio 25 mg / ml concentrate for solution for infusion SPC (L01XC07 bevacizumab) –
Bavencio 20 mg / ml concentrate for solution for infusion SPC (L01XC31 avelumab) Prescription only (POM)
Besponsa 1 mg powder for concentrate for solution for infusion SPC Prescription only (POM)
Blenrep SPC (L01XC39 belantamab mafodotin) Prescription only (POM)
Blenrep 100 mg powder for concentrate for solution for infusion SPC (L01XC39 belantamab mafodotin) Prescription only (POM)
Blincyto SPC (L01XC19 blinatumomab) Prescription only (POM)
Blincyto 38.5 micrograms powder for concentrate and solution for solution for infusion SPC (L01XC19 blinatumomab) Prescription only (POM)
Cyramza 10 mg / ml concentrate for solution for infusion SPC –
Darzalex 1 800 mg solution for injection SPC (L01XC24 daratumumab) Prescription only (POM)
Darzalex 20 mg / ml concentrate for solution for infusion SPC (L01XC24 daratumumab) –
Enhertu 100 mg powder for concentrate for solution for infusion SPC Prescription only (POM)
Equidacent SPC (L01XC07 bevacizumab) –
Erbitux 5 mg / ml solution for infusion SPC (L01XC06 cetuximab) –
Gazyvaro 1 000 mg concentrate for solution for infusion SPC (L01XC15 obinutuzumab) Prescription only (POM)
Herceptin 150 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) Prescription only (POM)
Herceptin 600 mg solution for injection in vial SPC (L01XC03 trastuzumab) Prescription only (POM)
Herzuma 150 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) Prescription only (POM)
Herzuma 420 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) Prescription only (POM)
Imfinzi 50 mg / ml concentrate for solution for infusion SPC (L01XC28 durvalumab) –
Jemperli 500 mg concentrate for solution for infusion SPC (L01XC40 dostarlimab) Prescription only (POM)
Kadcyla 100 mg powder for concentrate for solution for infusion SPC (L01XC14 trastuzumab emtansine) Prescription only (POM)
Kadcyla 160 mg powder for concentrate for solution for infusion SPC (L01XC14 trastuzumab emtansine) Prescription only (POM)
Kanjinti SPC no longer supplied (L01XC03 trastuzumab) –
Kanjinti 420 mg powder for concentrate for solution for infusion SPC no longer supplied (L01XC03 trastuzumab) –
Lartruvo SPC (L01XC27 olaratumab) –
Lextemy SPC (L01XC07 bevacizumab) –
Libtayo 350 mg concentrate for solution for infusion (L01XC33 cemiplimab) Prescription only (POM)
MabThera SPC (L01XC02 rituximab) Prescription only (POM)
Mabthera 1600 mg solution for subcutaneous injection SPC (L01XC02 rituximab) Prescription only (POM)
Mabthera 500 mg concentrate for solution for infusion SPC (L01XC02 rituximab) Prescription only (POM)
Minjuvi 200 mg powder for concentrate for solution for infusion SPC (L01XC35 tafasitamab) Prescription only (POM)
Mvasi SPC (L01XC07 bevacizumab) –
Mvasi 25 mg / ml Concentration for solution for infusion SPC (L01XC07 bevacizumab) –
Mylotarg 5 mg powder for concentrate for solution for infusion SPC (L01XC05 gemtuzumab ozogamicin) Prescription only (POM)
Nivolumab BMS SPC (L01XC17 nivolumab) –
Ogivri 150 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) Prescription only (POM)
Ogivri 420 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) Prescription only (POM)
Onbevzi SPC (L01XC07 bevacizumab) –
Ontruzant 150 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) Prescription only (POM)
Ontruzant 420 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) Prescription only (POM)
Opdivo 10 mg / ml concentrate for solution FO infusion (L01XC17 nivolumab) –
Oyavas SPC (L01XC07 bevacizumab) Prescription only (POM)
Perjeta 420 mg concentrate for solution for infusion SPC (L01XC13 pertuzumab) Prescription only (POM)
Polivy 140 mg powder for concentrate for solution for infusion SPC Prescription only (POM)
Poteligeo 4 mg/ml concentrate for solution for infusion (L01XC25 mogamulizumab) Prescription only (POM)
Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) SPC –
Qarziba 4.5 mg / ml concentrate for solution for infusion SPC (L01XC16 dinutuximab beta) Prescription only (POM)
Removab SPC no longer supplied (L01XC09 catumaxomab) –
Ritemvia SPC (L01XC02 rituximab) –
Rituzena (previously Tuxella) SPC (L01XC02 rituximab) –
Rixathon 100 mg concentrate for solution for infusion SPC (L01XC02 rituximab) Prescription only (POM)
Rixathon 500 mg concentrate for solution for infusion SPC (L01XC02 rituximab) Prescription only (POM)
Riximyo SPC (L01XC02 rituximab) –
Ruxience SPC (L01XC02 rituximab) Prescription only (POM)
Ruxience 500 mg concentrate for solution for infusion SPC (L01XC02 rituximab) Prescription only (POM)
Rybrevant 50 mg / ml concentrate for solution for infusion SPC Prescription only (POM)
Sarclisa 20 mg / ml concentrate for solution for infusion SPC (L01XC38 isatuximab) –
Tecentriq 840 mg concentrate for solution for infusion (L01XC32 atezolizumab) Prescription only (POM)
Trazimera 420 mg powder for concentrate for solution SPC (L01XC03 trastuzumab) Prescription only (POM)
Trodelvy 180 mg powder for concentrate for solution for infusion SPC Prescription only (POM)
Unituxin SPC –
Vectibix 20 mg / ml concentrate for solution for infusion SPC (L01XC08 panitumumab) –
Vegzelma 25 mg/ml concentrate for solution for infusion SPC (L01XC07 bevacizumab) –
Yervoy 5 mg / ml concentrate for solution for infusion (L01XC11 ipilimumab) –
Zercepac 150 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) Prescription only (POM)
Zercepac 420 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) Prescription only (POM)
Zercepac 60 mg powder for concentrate for solution for infusion SPC (L01XC03 trastuzumab) Prescription only (POM)
Zirabev 100 mg / 4 ml concentrate for solution for infusion SPC (L01XC07 bevacizumab) –

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group L01XC

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.